Livagen

Livagen is a four-residue peptide presented in the source guide as a bioregulator with proposed effects on DNA organization and cellular activity. Its potential relevance to aging, immune function, and nervous system biology remains investigational rather than established as a therapeutic benefit.

The source identifies its constituent amino acids, in order, as lysine, glutamate, aspartate, and alanine. It also associates Livagen with Epitalon, although the nature and significance of that relationship are not explained. Chromatin organization provides a biological context for the guide's proposed connections between this peptide and DNA-related processes.

The guide discusses reduced chromatin compaction as a possible mechanism, but the supplied notes do not establish how this would affect gene activity or cellular outcomes. It also proposes stimulation of immune activity and inhibition of enzymes involved in enkephalin breakdown. No specific enzyme identity, binding interaction, or experimentally validated pathway is provided.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 01 · Basic biology

A biological mechanism or molecular interaction is described. No claim about human outcomes.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide presents Livagen as a candidate for research into aging-related biology, immune responses, and neurological processes. It characterizes research tolerability favorably but supplies no study details in the extracted material. Its suggested literature searches additionally emphasize hepatic recovery and metabolic biology, topics not substantiated elsewhere in these notes.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The supplied material does not establish the experimental models, reproducibility, or clinical relevance of the proposed effects. The peptide's claimed relationship to Epitalon and its suggested liver-specific relevance require independent verification.

Safety data are limited, and the guide's favorable tolerability description is insufficient to establish a reliable risk profile. The extracted notes do not provide enough information to assess adverse effects or longer-term risks. This summary is educational and is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “Livagen liver function peptide”
• “Livagen bioregulator in liver regeneration”
• “Peptides for metabolic health”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN